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Abstract
Background A novel remotely controlled steerable guide cath-
eter has been developed to enable precise manipulation and
stable positioning of any eight French (Fr) or smaller
electrophysiological catheter within the heart for the purposes
of mapping and ablation.
Objective To report our initial experience using this system
for remotely performing catheter ablation in humans.
Methods Consecutive patients attending for routine ablation
were recruited. Various conventional diagnostic catheters were
insertedthroughtheleftfemoralveininpreparationfortreating
an accessory pathway (n=1), atrial flutter (n=2) and atrial
fibrillation (n=7). The steerable guide catheter was inserted
into the right femoral vein through which various irrigated
and non-irrigated tip ablation catheters were used. Conven-
tional endpoints of loss of pathway conduction, bidirectional
cavotricuspid isthmus block and four pulmonary vein
isolation were used to determine acute procedural success.
Results Ten patients underwent remote catheter ablation using
conventional and/or 3D non-fluoroscopic mapping technolo-
gies. All procedural endpoints were achieved using the robotic
control system without manual manipulation of the ablation
catheter. There was no major complication. A radiation
dosimeter positioned next to the operator 2.7 m away from
the X-ray source showed negligible exposure despite a mean
cumulative dose area product of 7,281.4 cGycm
2 for all ten
ablation procedures.
Conclusions Safe and clinically effective remote navigation
of ablation catheters can be achieved using a novel remotely
controlled steerable guide catheter in a variety of arrhyth-
mias. The system is compatible with current mapping and
ablation technologies Remote navigation substantially
reduces radiation exposure to the operator.
Keywords Roboticnavigation.Catheterablation.
Remotenavigation
1 Introduction
Mapping and catheter ablation of cardiac arrhythmias can be
technically complex and challenging. Currently the majority
of suchprocedures are performed using manually deflectable
catheters. These catheters have limited range and flexibility
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A novel electromechanical master/slave system that can
remotely control a steerable guide catheter (Hansen Medical,
Inc.,MountainView,CA,USA)hasbeendevelopedtoenable
precise positioning and manipulation of any type of electro-
physiological catheter within the heart for the purposes of
mapping and ablation. The system comprises three linked
components: the physician’s workstation (Sensei™ robotic
control system), remote catheter manipulator (RCM) and
steerable guide catheter (Artisan™ Control Catheter) (Fig. 1).
1.1 The physician’s workstation
The physician’s workstation consists of display screens for
contact intracardiac electrophysiology data and 3D map-
ping systems as well as a central fluoroscopic control view
also displaying a superimposed icon of the Artisan Control
Catheter (Fig. 2). Integral to the workstation and its control
of the Artisan is the Instinctive Motion Controller (IMC);
effectively a 3-dimensional hand operated joystick. The
position of the IMC handle is calculated from internal
sensors, and this position is fed to control computers in a
separate electronics rack which in turn guides the remote
catheter manipulator (RCM).
1.2 Remote catheter manipulator
The RCM is a robot designed to accept the Artisan catheter.
The RCM receives catheter position commands from the
control computers as issued by the IMC. Acting on these
commands,theRCMusesservomotorstocontrolitsmotions.
These motions transfer to the Artisan catheter’s pull wires,
ultimately determining the position of the catheter tip.
1.3 Steerable guide catheter (Artisan)
The Artisan is a single use sterile guide catheter that is
composed of two parts: a steerable inner guide within a
steerable outer guide (Fig. 3). The outer guide catheter
(outer size 14 Fr, inner size 11 Fr), controlled by two pull
wires 180° apart, provides a stable base for the inner guide
(11 Fr outer, 8.5 Fr inner). Four orthogonal pull wires
deflect the inner guide catheter in x and y d i r e c t i o ns oi t
can reach anywhere within a roughly toroidal workspace
d e f i n e db yb e n do fu pt o2 7 0 °a n d1 0c me x t e n s i o n .B o t h
sheath movements are controlled by the operator. Com-
bined with the RCM’s ability to insert the entire Artisan
forward and rotate it, the tip has a versatile reach.
Conventional 8 Fr or smaller mapping and ablation
catheters are inserted through the inner guide catheter
and locked in place at the proximal end of the Artisan. The
deflection mechanisms of these catheters are not required
and remain within the Artisan. The only part of the
catheters to protrude from the tip of the Artisan control
catheter are the distal bipole and occasionally the proximal
bipole, as determined by the operator on insertion of the
conventional catheter into the Artisan.
We report our initial experience in testing the hypothesis
that robotic remote catheter ablation in humans is feasible
and safe using existing catheters and mapping systems.
This study was approved by St. Mary’s Hospital local ethics
committee.
2 Materials and methods
Consecutive patients meeting inclusion criteria and without
exclusion criteria (Table 1) were recruited. As part of the
Fig. 1 The remote catheter manipulator (RCM) (left) is attached to the steerable guide catheter (Artisan™) through which a mapping catheter can
be positioned within the heart. The physician’s workstation (right) navigates the steerable guide catheter remotely
20 J Interv Card Electrophysiol (2008) 21:19–26initial safety protocol, ten patients underwent remote mapping
only and these patients subsequently underwent conventional
ablation after the steerable guide catheter was removed. A
further ten patients underwent both remote mapping and
ablation using the Artisan, the results of which are presented
in this paper. Informed written consent was obtained from all
patients prior to the procedure. All were studied in the fasted
state with or without intravenous sedation.
Various diagnostic catheters were inserted and manipu-
lated manually through the left femoral vein for initial
arrhythmia mapping. These included Josephson™ quad-
ripolar catheters in combination with Cardima™, Halo™
and Lasso™ catheters for mapping a left lateral accessory
pathway, two atrial flutter circuits and for seven atrial
fibrillation ablation procedures respectively.
Transeptal access was performed to treat the patients with
an accessory pathway and atrial fibrillation. In the cases of
atrial fibrillation ablation, a single transeptal puncture was
made from the left femoral vein, the needlewas removed, the
sheath withdrawn into the right atrium and an .035 J-wire left
across the puncture site. The Artisan containing the ablation
catheter was then guided from the right femoral vein through
the puncture site into the left atrium for ablation. It is useful
to note that although the outer guide is able to cross the inter-
atrial septum, for the majority of cases, this remains on the
Fig. 2 The Instinctive Motion Controller (top left) used with a control
panel on the physician’s workstation (bottom left) remotely guides the
steerable guide catheter which can be seen on the central “control
view” display (right). Real-time data on catheter orientation, catheter-
tip pressure, fluoroscopic views as well as intracardiac echocardiog-
raphy are shown
Fig. 3 The Artisan control catheter and its components. SIG Steerable
inner guide, SOG steerable outer guide
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Suitable for catheter
mapping/ablation
Severe cerebrovascular disease
18–85 years of age Serum creatinine > 2.5
Body Mass Index < 40 Active gastrointestinal bleeding
Signed informed
consent
Active infection or fever
Short life expectancy <1 year
Significant anemia
Severe electrolyte imbalance
Allergy to contrast
Congestive heart failure
(NYHA Class IV), ejection fraction <30%
Unstable angina requiring emergent
percutaneous intervention
Recent myocardial infarction
within 2 weeks
Bleeding or clotting disorders
Uncontrolled diabetes
Inability to receive IV anticoagulants
J Interv Card Electrophysiol (2008) 21:19–26 21 21right atrial side of the septum and catheter navigation within
the left atrium was done mainly using the inner sheath. The
pulmonary veins were mapped manually with a Lasso™
placed via the left femoral transeptal sheath. For left-sided
procedures titrated intravenous heparin boluses of up to
10,000 units were given every 30 min to maintain an
activated clotting time of at least 300 s.
The Artisan control catheter was inserted into the right
femoral vein through a short non-irrigated 14 Fr sheath.
Various conventional 4 and 8 mm non-irrigated tip (EPT
Blazer II™) and irrigated-tip (Navistar™ Thermocool™)
catheters were deployed through the lumen of the Artisan
for ablation. Continuous heparinised saline flushing was
maintained through the side ports of the inner and outer
sheaths of the Artisan.
Conventional mapping was complemented with 3D non-
fluoroscopic mapping technologies as required, including
NavX™ (St. Jude Medical, St. Paul, MN, USA), CARTO™
and CARTOMERGE™ (Biosense Webster Inc., Diamond
Bar, CA, USA).
All 3D maps, computed tomography scan registration,
mapping and ablation were performed remotely. In the atrial
fibrillation cases some ablation points were ‘drag’ lesions
used to construct ablation lines.
Conventional endpoints of loss of accessory pathway
function, bidirectional cavotricuspid isthmus block and four
pulmonary vein isolation were used to determine immediate
procedural success.
At the end of the procedure the Artisan was removed
from the 14 Fr venous sheath manually. If heparin had been
given during the procedure, intravenous protamine was
administered and removal of the 14 Fr sheath was done
under manual pressure once the activated clotting time was
less than 150 s.
3 Results
Twenty patients were studied. In ten, only mapping to
specific anatomical sites was performed using the Hansen
system for regulatory purposes without any procedural
complication related to using the system. The other ten
patients underwent remote catheter ablation and are the
subjects of this report. All mapping and ablation endpoints
were achieved using only the Sensei robotic control system,
withoutmanualmanipulationoftheablationcatheterinthese
ten patients.
Table2 shows the procedures undertaken, equipment used,
radiation exposure, procedural and ablation times. (Note that
ablation times are taken from the first application to the last
application of radiofrequency energy. All RF applications
were given for up to 1 min at a time). Figures 4 and 5 show
Table 2 Robotic ablation procedural data
Patient Sex Age Diagnosis Procedure Mapping system Catheter
tip
Number of
RFs
RF
time
Total
procedure
time
Flouro
time
Patient
DAP
Workstation
DAP
1 F 76 Atrial flutter CTI conventional 4 mm
irrigated
38 103 140 44.5 8,383 0
2 M 55 Permanent atrial
fibrillation
PVI, left
atrial maze
NavX™ 4m m
irrigated
63 191 259 116 24,667 0
3 M 50 Paroxysmal atrial
fibrillation
PVI NavX™ 4m m
irrigated
42 111 170 52 11,216 0
4 M 41 Accessory
pathway
Pathway
ablation
conventional 4 mm
non-irrigated
3 31 106 13.4 779 0
5 F 71 Atrial flutter CTI conventional 8 mm
non-irrigated
15 33 70 19.9 1,042 0
6 M 53 Persistent atrial
fibrillation
PVI roof
line, MI
NavX™ 4m m
irrigated
39 123 165 55.2 6,577 0
7 M 73 Persistent atrial
fibrillation
PVI and
roof line
NavX™ 4m m
irrigated
46 143 166 64.2 4,739 0
8 F 63 Paroxysmal atrial
fibrillation
PVI and
roof line
NavX™ 4m m
irrigated
48 118 157 42.8 7,271 0
9 F 46 Atrial ectopy/
paroxysmal atrial
fibrillation
PVI CARTOMERGE™ 4m m
irrigated
31 143 124 41.7 2,262 0
10 M 54 Persistent atrial
fibrillation
PVI and
roof line
CARTO™ 4m m
irrigated
68 155 223 43.4 5,878 0
[CTI cavotricuspid isthmus line, PVI pulmonary vein isolation, MI mitral isthmus, line, RF radiofrequency ablation. RF time – time from first RF
to the end of the last RF. All times are in minutes. Radiation exposures are expressed as dose area product DAP (cGycm
2).]
22 J Interv Card Electrophysiol (2008) 21:19–26examples of the use of the steerable catheter in combination
with each mapping system.
No major complication occurred. One patient (accessory
pathway) had a small <1 cm pericardial effusion measured
on echocardiogram 24 h post-procedure. The patient was
not on post-procedural anticoagulation and was discharged
without any clinical sequalae. There were no femoral
haematomas associated with the use of the system.
A radiation dosimeter (Mydose Mini X, Aloka Co. Ltd.,
Japan) positioned at the physician’s workstation approximate-
ly 2.7 m away from the X-ray source demonstrated negligible
exposure to the operator despite a mean cumulative dose area
product of 7,281.4 cGycm
2 for all ten ablation procedures.
4 Discussion
Complex ablation procedures to treat cardiac arrhythmias
can be time consuming and technically challenging. There is
always a need to improve procedural success, reduce
procedure times and minimize fluoroscopy screening times.
These issues are largely governed by the skill and efficiency
Fig. 4 Examples of the use of the remotely controlled catheter sheath
in conventional electrophysiological procedures. LAO projection of a
left free wall accessory pathway ablation (left) and PA projection of
segmental right upper pulmonary vein isolation (right). (SGC steerable
guide catheter, Abl ablation catheter tip)
Fig. 5 Non-fluoroscopic mapping system images created using the
remotely controlled steerable guide catheter. Anteroposterior view of
the left and right atrial geometry using NavX™ (top left) and
posteroanterior view of the left atrium during wide area circumferen-
tial ablation using CARTO™ (top right). Posteroanterior view of the
left atrium (bottom left) and cross-sectional view of the left sided
pulmonary veins (bottom right) during segmental pulmonary vein
isolation using CARTOMERGE™. (Ablation lesions in red)
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be limited in their flexibility and manoeuvrability. Computer
assisted remote catheter ablation systems may minimize
some of these difficulties by reducing the manual skill
required, potentially reducing the operator’s learning curves.
The potential advantages of remote ablation include
improved catheter manoeuvrability, precision and especially
stability in areas within the heart which may be difficult to
reach manually and the ability to reproducibly and
accurately return to sites of interest during a procedure.
Another remotely controlled catheter technology in current
clinical use involves magnetic tipped catheters that are
directed within a magnetic field. Its efficacy has already
been demonstrated in mapping and ablation of accessory
pathways, atrial, nodal and ventricular arrhythmias [1–5].
Electromechanical systems are an alternative means of
remote catheter ablation. An in-depth comparison of the
advantages and disadvantages of both systems is beyond
the remit of this paper; particularly as robotic catheter
navigation has only just been developed whereas magnetic
navigation has already established itself in clinical trials.
However, one can see the advantages of being able to use a
remote navigation system that is portable; does not exclude
patients that have metal implants or devices and is
compatible with other mapping systems and catheters. It
remains to be seen whether robotic navigation can achieve
the long-term efficacy and safety of magnetic navigation. In
particular, whilst catheter-tip stability is improved, the
amount of energy applied and the duration needed to
achieve successful ablation without increasing the risk of
“pops” and resultant perforation needs to be determined.
Robotic systems have already been used in surgical
procedures, demonstrating improved precision, stability and
dexterity [6]. Our study has shown that the Sensei robotic
system in combination with the Artisan control catheter is
safe, feasible and effective in achieving conventional
endpoints in mapping and ablation within the human heart.
4.1 Safety
Previousstudieswithporcinemodelsaswellasasmallhuman
study have shown its safety in vivo [7–9]. A potential prob-
lem with a remote catheter control system is the lack of
mechanical feedback that one would receive from manually
controlling a catheter. This is important in assessing how
much force is being applied in moving and maintaining
catheter tip position. Knowledge of this force is important in
avoiding damage to or perforation of cardiac and vascular
structures. A system called Intellisense™ Fine Force
Technology uses two force sensors that grip the shaft of
the working catheter as it protrudes from the Artisan catheter.
The working catheter is pulsed a short distance (<1.5 mm) in
and out of the Artisan four times each second and with each
pulse, coaxial force data are collected and compared. Forces
applied to the working catheter tip are measured and
displayed on the main screen as visual feedback of force
(Fig. 6). This does not provide feedback on all the
multidirectional forces applied to all parts of the catheter
and, whilst it would be ideal to receive mechanical feedback
through the instinctive motion controller, the visual data
provided on the most important part of the catheter helps the
operator to overcome this potential problem.
In the authors’ personal experience using this system,
although visual representation of the forces applied at the
catheter tip is better than none at all, it does not replace the
tactile responses that experienced operators use to prevent
Fig. 6 The Intellisense system display (close-up edited view). Coaxial
forces sensed at the catheter tip are displayed as a realtime waveform
strip chart and gauge. On the strip chart there is a “warning level”
threshold which is set by the operator. When forces exceed this level,
the tip of the animated catheter changes colour (from white to yellow),
and the strip chart plot line changes colour as well
Table 3 Conventional ablation procedural data
Ablation procedure Number RFs RF time Total procedure time Flouro time DAP
Atrial fibrillation – 111±51 (44–171) 143±52 (45–204) 61.4±31 (24–121) 6,636±5,867 (1,776–19,489)
Atrial flutter 7±5 (2–18) 21±16 (4–56) 62±24 (25–94) 23±13.3 (7–49) 1,369±1,108 (189–3,596)
Accessory pathway 3±3 (1–11) 14±25 (1–83) 97±53 (36–186) 22.9±12.2 (9–44) 2,899±3,224 (219–11,055)
Figures represents data taken from conventional procedures (n=10) for each arrhythmia type. Means are given with standard deviations and
ranges. Times are in minutes. RF—radiofrequency energy lesion. Dose area product (DAP) in cGycm
2.
24 J Interv Card Electrophysiol (2008) 21:19–26damage or perforation of cardiac structures. The Intellisense
system allows the operator to predetermine what pressure
level is deemed to be ‘excessive’ and if pressures exceed
this arbitrary threshold the tip of the virtual catheter and the
pressure waveform changes colour as a warning but there is
no auditory alarm, requiring the operator to be constantly
vigilant.
Another potential problem is the potential for thrombus
to form within the Artisan’s sheaths. This was avoided by
high flow continuous flushing and appropriate heparin-
isation. No thrombotic complication occurred in this study.
4.2 Fluoroscopy and radiation exposure
Complex ablation procedures such as for atrial fibrillation
can be lengthy and radiation exposure to both patients and
operators remains a concern. The present study does not
fully represent the potential for a robotic system to reduce
X-ray exposure to patients. For the operator, during
conventional ablation procedures, despite adequate radia-
tion protection, areas such as the face and extremities are
still subject to scattered radiation exposure which impacts
on cumulative dose [10, 11]. Our study has shown that
negligible operator radiation exposure can already be
achieved from being less than 3 m away from the radiation
source whilst still being within the laboratory, potentially
reducing the long-term risks to operators from radiation.
Once the learning curve is overcome and procedure times
improve, when used fully in combination with non-
fluoroscopic mapping systems, robotic ablation could
potentially reduce patient radiation exposure as well.
4.3 Versatility
This study has demonstrated the system’s compatibility with
various irrigated and non-irrigated tipped ablation catheters
as well as its use with existing non-fluoroscopic mapping
systems such as CARTO™ and NavX™. There was no
technical difficulty in setting up and performing mapping
and ablation in any of the cases. In the case using a Ther-
mocool Navistar 8 mm tip catheter, insertion into the Artisan
was not problematic, though the fit prevented the Intellisense
force feedback system from moving the catheter tip.
Mapping and ablation was performed unhindered but with
the Intellisense system switched off.
5 Limitations
This is a small feasibility study therefore conclusions with
regards to overall efficacy and efficiency of the system for
each type of arrhythmia cannot be made. For comparison,
averaged data from conventional procedures (n=10 for
each) undertaken at our laboratory are shown in Table 3.
It should be noted that this data represents the work of
several operators of varying skill and experience. The
robotic atrial fibrillation data (RF time 140±27 min,
procedure time 181±45 min, n=7) show that times are
longer on average compared to conventional procedures.
This is not surprising as, with any new device, there is a
learning curve to its use.
The operators themselves underwent an intensive two
day training course to familiarise themselves with the set-up
and use of the equipment in animals prior to the study being
undertaken. During the animal case the physician is
instructed in how to drive to certain places in the right
atrium, how to cross the septum and drive to defined points
in the left atrium and also how to create a 3D atrial
geometry. It is understandable that great caution was
employed with its use in the first human subjects. Despite
this, the data are sufficient to conclude that the system can
work safely and effectively in humans and can achieve
conventional endpoints of ablation.
6 Conclusions
The Sensei robotic control system in combination with the
Artisan control catheter is compatible with current mapping
and ablation technologies, enabling clinically effective
remote navigation of ablation catheters. Remotely con-
trolled catheter ablation for cardiac arrhythmias using this
system reduces operator radiation exposure.
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